Key Takeaways from the BIO International Convention 2022

Nicole Brenna, US Business Development Director, represented Cromos Pharma at the BIO International Convention. Please read her key takeaways from the event.

“This was my first BIO conference in person and it was great meeting Sponsors and our partners from all over the world. It was definitely nice to finally shake hands and exchange business cards, as everything over the last two years has been virtual. 

The BIO One-on-One Partnering was very beneficial as it allowed for individuals to speak one-on-one for 30 minutes without interruption. I have noticed in the past at conferences, it can be quite difficult to find a quiet place to speak about study details without others hearing, so the individual partnering rooms was the perfect solution. 

There was a lot of discussion around patient diversity in clinical trials and the importance of including this in studies. Decentralized clinical trials continues to be a hot topic, as we slowly come out of the pandemic. I spoke with a lot of Sponsors who are working in the rare disease space and they stressed how enrollment can be quite challenging.  With that being said, it was great to hear Venus Williams speak about her personal struggle with having a rare disease and how she functions daily and keeps a positive outlook on life,” said Nicole Brenna.

About Cromos Pharma

Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range  of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.

Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials. 

We provide accelerated study  start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.

Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.

If you have any questions or want to find out more about how Cromos Pharma can support your next clinical program please get in touch with us by emailing inquiry@cromospharma.com.